← Leaderboards
Jill P Crandall
Mount Sinai School Of Medicine Of Cuny
$14,281,706
Attributed
$14,466,071
Total exposure
17
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,466,071 · 17
By mechanism
U01$8,463,181 · 1
P30$2,287,246 · 5
P01$2,281,978 · 1
M01$1,064,935 · 9
R21$368,731 · 1
Top collaborators
- Pinchas Cohen2 shared
Most similar at Mount Sinai School Of Medicine Of Cuny
Same institution · by research overlap
- Pramod K Mistry$2,098,085
Others in their field
Top investigators on “Diabetes Mellitus”
- Jeffrey P Krischer · University Of South Florida$608,226,434
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$177,347,135
- John M Lachin · George Washington University$155,262,668
- David M Nathan · Massachusetts Institute Of Technology$142,806,023
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Jose A Luchsinger · Columbia University Health Sciences$75,551,718
Research focus
Diabetes MellitusCohortProgramsFollow-UpMetforminBasePreventMetabolicDiabetes Prevention ProgramDesignDiabetes PreventionMedicineLife StyleObesityAtherosclerosisClinical ResearchIncidencePlacebosCommunitiesServicesLaboratoriesAffectLifestyle InterventionNon-Insulin-Dependent Diabetes Mellitus
Grant awards (57)
NYR-Diabetes Research Center (NYR-DRC)$345,304
P30 · FY2025 · DK · contact PI
Einstein Mount Sinai Diabetes Research Center$178,982
P30 · FY2024 · DK · contact PI
Einstein Mount Sinai Diabetes Research Center$178,982
P30 · FY2023 · DK · contact PI
Einstein Mount Sinai Diabetes Research Center$178,982
P30 · FY2022 · DK · contact PI
Einstein Mount Sinai Diabetes Research Center$178,982
P30 · FY2021 · DK · contact PI
20/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) â Clinical Center$1
U01 · FY2021 · DK · contact PI
20/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project$433,798
U01 · FY2020 · DK · contact PI
Einstein Mount Sinai Diabetes Research Center$177,259
P30 · FY2020 · DK · contact PI
20/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project$446,167
U01 · FY2019 · DK · contact PI
Translational Research Core$210,568
P30 · FY2019 · DK · contact PI
20/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project$320,562
U01 · FY2018 · DK · contact PI
20/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project$141,175
U01 · FY2018 · DK · contact PI
Translational Research Core$118,145
P30 · FY2018 · DK · contact PI
Translational Research Core$92,502
P30 · FY2018 · DK · contact PI
20/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project$365,566
U01 · FY2017 · DK · contact PI
Translational Research Core$210,568
P30 · FY2017 · DK · contact PI
20/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project$417,500
U01 · FY2016 · DK · contact PI
Translational Research Core$210,568
P30 · FY2016 · DK · contact PI
20/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project$71,810
U01 · FY2016 · DK · contact PI
20/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project$32,066
U01 · FY2016 · DK · contact PI
Diabetes Prevention Program Long-Term Follow-up Study$181,753
U01 · FY2015 · DK · contact PI
Diabetes Prevention Program Long-Term Follow-up Study$164,846
U01 · FY2015 · DK · contact PI
Translational Research Core$118,666
P30 · FY2015 · DK · contact PI
Translational Research Core$87,738
P30 · FY2015 · DK · contact PI
Diabetes Prevention Program Long-Term Follow-up Study$435,176
U01 · FY2014 · DK · contact PI
Diabetes Prevention Program Long-Term Follow-up Study$575,505
U01 · FY2013 · DK · contact PI
Diabetes Prevention Program Long-Term Follow-up Study$620,196
U01 · FY2012 · DK · contact PI
Humanin and Type 2 Diabetes$192,640
R21 · FY2012 · DK · contact PI
CLINICAL CORE$19,046
P01 · FY2012 · AG · contact PI
Diabetes Prevention Program Long-Term Follow-up Study$558,422
U01 · FY2011 · DK · contact PI
CLINICAL CORE$363,166
P01 · FY2011 · AG · contact PI
Humanin and Type 2 Diabetes$176,091
R21 · FY2011 · DK · contact PI
Diabetes Prevention Program Long-Term Follow-up Study$521,776
U01 · FY2010 · DK · contact PI
CLINICAL CORE$413,845
P01 · FY2010 · AG · contact PI
Diabetes Prevention Program Long-Term Follow-up Study$508,196
U01 · FY2009 · DK · contact PI
CLINICAL CORE$427,362
P01 · FY2009 · AG · contact PI
CLINICAL CORE$506,267
P01 · FY2008 · AG · contact PI
Post-DPP Follow-Up Study$477,621
U01 · FY2008 · DK · contact PI
DPPOS$55,457
M01 · FY2008 · RR · contact PI
CVRISK$10,129
M01 · FY2008 · RR · contact PI
CLINICAL CORE$552,292
P01 · FY2007 · AG · contact PI
Post-DPP Follow-Up Study$281,957
U01 · FY2007 · DK · contact PI
DPPOS$161,997
M01 · FY2007 · RR · contact PI
CVRISK$94,862
M01 · FY2007 · RR · contact PI
Post-DPP Follow-Up Study$504,210
U01 · FY2006 · DK · contact PI
DPPOS$139,021
M01 · FY2006 · RR · contact PI
CVRISK$94,043
M01 · FY2006 · RR · contact PI
Post-DPP Follow-Up Study$392,542
U01 · FY2005 · DK
DPPOS$170,342
M01 · FY2005 · RR
CVRISK$121,895
M01 · FY2005 · RR
Post-DPP Follow-Up Study$495,295
U01 · FY2004 · DK
DPPOS$123,182
M01 · FY2004 · RR
CVRISK$25,219
M01 · FY2004 · RR
Post-DPP Follow-Up Study$517,041
U01 · FY2003 · DK
THROMBOGENICITY IN DIABETES MELLITUS$0
M01 · FY2002 · RR
THROMBOGENICITY IN DIABETES MELLITUS$0
M01 · FY2001 · RR
THROMBOGENICITY IN DIABETES MELLITUS$68,788
M01 · FY2000 · RR